Table 1:
Patients undergoing carotid angioplasty with stenting using the Parodi Anti-Emboli System in Mie University Hospital from 2003 to 2004
| Patient No./Age (y)/Sex | Side | Symptom before Treatment | Systemic Complication | Stenosis Ratio (%) | Postprocedural Stenosis (%) | Occlusion Time during Procedure (s) | Control ACT (s) | ACT during Procedure (s) | Prolonged ACT times | Predilation | Stent | MRI-DWI Findings after Procedure (High-Signal Spot) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1/71/M | R | Asymptomatic | HTN | 90 | 10 | 418 | 148 | 222 | 1.50 | (−) | SMARTeR | (−) |
| 2/88/M | L | TIA | HTN | 90 | 30 | 660 | 150 | 318 | 2.12 | (+) | SMARTeR | (−) |
| 3/69/M | R | Asymptomatic | DM, HL | 90 | 15 | 964 | 161 | 304 | 1.89 | (+) | SMARTeR | (−) |
| 4/75/M | R | TIA (Amaurosis) | DM | 90 | 10 | 683 | 151 | 389 | 2.58 | (+) | SMARTeR | (−) |
| 5/62/M | R | Minor | (−) | 80 | 15 | 600 | 138 | 286 | 2.07 | (+) | SMARTeR | (−) |
| 6/69/M | L | Minor | HL | 90 | 5 | 420 | 133 | 250 | 1.88 | (−) | SMARTeR | (−) |
| 7/61/M | R | Asymptomatic | DM, HTN | 90 | 0 | 830 | 167 | 523 | 3.13 | (+) | SMARTeR | (−) |
| 8/63/M | L | Major | DVT | 70 | 5 | 624 | 167 | 344 | 2.06 | (+) | SMARTeR | (+) |
| 9/65/M | L | Asymptomatic | HTN, HL | 70 | 10 | 517 | 137 | 337 | 2.46 | (−) | SMARTeR | (+) |
| 10/77/M | L | Minor | CRF, OMI | 90 | 5 | 1354 | 144 | 428 | 2.97 | (+) | SMARTeR | (−) |
| 11/66/M | R | Minor | DM | 95 | 5 | 931 | 110 | 254 | 2.31 | (+) | Protege | (−) |
Note:—ACT indicates activated clotting time; MRI-DWI, magnetic resonance imaging–diffusion weighted imaging; TIA, transient ischemia attack; HTN, hypertension; DM, diabetes mellitus; HL, hyperlipidemia; DVT, deep venous thrombosis; CRF, chronic renal failure; OMI, old myocardial infarction.
Averages are as follows: age, 69.7 ± 7.8 years; stenosis ratio, 85.4 ± 8.5%; occlusion time, 722.5 ± 255.2 seconds; ACT (control), 146.1 ± 15.2 seconds; ACT (during procedures, 329.5 ± 80.7 seconds.